间皮瘤中的BAP1损失:分子机制和临床机会
Jasper H L T van Genugten1,2, Dean A Fennell3, Paul Baas4
1Department of Thoracic Oncology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. j.v.genugten@nki.nl.
Oncogene
|January 7, 2026
概括
失去了BAP1瘤抑制基因在间皮瘤中很常见. 这篇评论探讨了BAP1的情况.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 间皮瘤是一种侵袭性癌症.
- 失去BRCA1关联蛋白1 (BAP1) 瘤抑制基因是中皮瘤中常见的早期事件.
- BAP1在基因表达,DNA修复和细胞代谢中发挥着关键作用.
研究的目的:
- 审查BAP1在间皮瘤中的分子功能.
- 探索如何将临床前发现转化为治疗BAP1缺陷性间皮瘤的临床疗法.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 对BAP1缺陷美索瘤脆弱性的临床前数据的分析.
- 讨论潜在的治疗策略.
主要成果:
- BAP1的损失会影响多个细胞过程,从而在间皮瘤中形成漏洞.
- 临床前研究表明对EZH2,HDAC,PARP和FGFR抑制剂的敏感性.
- 将这些临床前发现转化为有效的临床治疗仍然是一个重大挑战.
结论:
- 了解BAP1的功能对于开发向性间皮瘤疗法至关重要.
- 准BAP1缺陷大脑细胞瘤有望改善患者的治疗结果.
- 需要进一步的研究来弥合临床前发现和临床应用之间的差距.
相关概念视频
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K